当前位置: X-MOL 学术J. Muscle Res. Cell. Motil. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
2-D08 treatment regulates C2C12 myoblast proliferation and differentiation via the Erk1/2 and proteasome signaling pathways
Journal of Muscle Research and Cell Motility ( IF 2.7 ) Pub Date : 2021-06-17 , DOI: 10.1007/s10974-021-09605-x
Hyunju Liu 1 , Su-Mi Lee 2, 3 , Hosouk Joung 2, 3
Affiliation  

SUMOylation is one of the post-translational modifications that involves the covalent attachment of the small ubiquitin-like modifier (SUMO) to the substrate. SUMOylation regulates multiple biological processes, including myoblast proliferation, differentiation, and apoptosis. 2-D08 is a synthetically available flavone, which acts as a potent cell-permeable SUMOylation inhibitor. Its mechanism of action involves preventing the transfer of SUMO from the E2 thioester to the substrate without influencing SUMO-activating enzyme E1 (SAE-1/2) or E2 Ubc9-SUMO thioester formation. However, both the effects and mechanisms of 2-D08 on C2C12 myoblast cells remain unclear. In the present study, we found that treatment with 2-D08 inhibits C2C12 cell proliferation and differentiation. We confirmed that 2-D08 significantly hampers the viability of C2C12 cells. Additionally, it inhibited myogenic differentiation, decreasing myosin heavy chain (MHC), MyoD, and myogenin expression. Furthermore, we confirmed that 2-D08-mediated anti-myogenic effects impair myoblast differentiation and myotube formation, reducing the number of MHC-positive C2C12 cells. In addition, we found that 2-D08 induces the activation of ErK1/2 and the degradation of MyoD and myogenin in C2C12 cells. Taken together, these results indicated that 2-D08 treatment results in the deregulated proliferation and differentiation of myoblasts. However, further research is needed to investigate the long-term effects of 2-D08 on skeletal muscles.



中文翻译:

2-D08 治疗通过 Erk1/2 和蛋白酶体信号通路调节 C2C12 成肌细胞增殖和分化

SUMOylation 是一种翻译后修饰,它涉及小泛素样修饰剂 (SUMO) 与底物的共价连接。SUMOylation 调节多种生物学过程,包括成肌细胞增殖、分化和凋亡。2-D08 是一种合成可用的黄酮,可作为有效的细胞渗透性 SUMOylation 抑制剂。其作用机制包括防止 SUMO 从 E2 硫酯转移到底物,而不影响 SUMO 活化酶 E1 (SAE-1/2) 或 E2 Ubc9-SUMO 硫酯的形成。然而,2-D08对C2C12成肌细胞的作用和机制仍不清楚。在本研究中,我们发现用 2-D08 处理可抑制 C2C12 细胞增殖和分化。我们证实 2-D08 显着阻碍 C2C12 细胞的活力。此外,它还抑制肌原性分化,降低肌球蛋白重链 (MHC)、MyoD 和肌细胞生成素的表达。此外,我们证实 2-D08 介导的抗生肌作用会损害成肌细胞分化和肌管形成,从而减少 MHC 阳性 C2C12 细胞的数量。此外,我们发现 2-D08 在 C2C12 细胞中诱导 ErK1/2 的激活以及 MyoD 和肌细胞生成素的降解。总之,这些结果表明2-D08处理导致成肌细胞增殖和分化失调。然而,需要进一步研究来调查 2-D08 对骨骼肌的长期影响。我们证实 2-D08 介导的抗肌生成作用会损害成肌细胞分化和肌管形成,从而减少 MHC 阳性 C2C12 细胞的数量。此外,我们发现 2-D08 在 C2C12 细胞中诱导 ErK1/2 的激活以及 MyoD 和肌细胞生成素的降解。总之,这些结果表明2-D08处理导致成肌细胞增殖和分化失调。然而,需要进一步研究来调查 2-D08 对骨骼肌的长期影响。我们证实 2-D08 介导的抗肌生成作用会损害成肌细胞分化和肌管形成,从而减少 MHC 阳性 C2C12 细胞的数量。此外,我们发现 2-D08 在 C2C12 细胞中诱导 ErK1/2 的激活以及 MyoD 和肌细胞生成素的降解。总之,这些结果表明2-D08处理导致成肌细胞增殖和分化失调。然而,需要进一步研究来调查 2-D08 对骨骼肌的长期影响。这些结果表明,2-D08 处理导致成肌细胞增殖和分化失调。然而,需要进一步研究来调查 2-D08 对骨骼肌的长期影响。这些结果表明,2-D08 处理导致成肌细胞增殖和分化失调。然而,需要进一步研究来调查 2-D08 对骨骼肌的长期影响。

更新日期:2021-06-18
down
wechat
bug